Arthroplasty Versus Internal Fixation for Undisplaced Femoral Neck Fracture

NCT04075461 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 330

Last updated 2025-03-25

No results posted yet for this study

Summary

This is the world's first national orthopedic randomized controlled trial (RCT) involving 19 out of 21 departments in Denmark. Each year, 7,000 patients suffer a hip fracture. This is a severe condition leading to 25% mortality after 1 year and 40% do not recover to the same functional level. The aim is to compare two surgical treatment methods (metal fixation versus artificial hip) in patients above 65 years with an undisplaced femoral neck fracture. The hypothesis is that even though an artificial hip is a larger surgical procedure than metal fixation of the broken bone, the artificial hip is more stable with less pain due the lack of a healing broken bone and therefore leads to a better and quicker mobilization after surgery. Better mobilization is one of the most important factors for decreasing mortality. We have chosen a pragmatic RCT design by using the local departmental implants. We hope that the knowledge from this study will therefore easily be implemented afterwards.

Conditions

  • Undisplaced Fracture
  • Femoral Neck Fractures
  • Internal Fixation; Complications
  • Arthroplasty Complications

Interventions

PROCEDURE

Arthroplasty

Arthroplasty is commonly used for a displaced femoral neck fracture.

PROCEDURE

Internal fixation

Internal fixation is commonly used for undisplaced femoral neck fracture

Sponsors & Collaborators

  • Aalborg University Hospital

    collaborator OTHER
  • Regionshospital Nordjylland

    collaborator OTHER_GOV
  • Aarhus University Hospital

    collaborator OTHER
  • Odense University Hospital

    collaborator OTHER
  • Slagelse Hospital

    collaborator OTHER
  • Bispebjerg Hospital

    collaborator OTHER
  • Regionshospitalet Viborg, Skive

    collaborator OTHER
  • Randers Regional Hospital

    collaborator OTHER
  • Regionshospitalet Horsens

    collaborator OTHER
  • Hospital of Southern Jutland

    collaborator OTHER
  • Esbjerg Hospital - University Hospital of Southern Denmark

    collaborator OTHER
  • Hvidovre University Hospital

    collaborator OTHER
  • Herlev Hospital

    collaborator OTHER
  • Hillerod Hospital, Denmark

    collaborator OTHER
  • Holbaek Sygehus

    collaborator OTHER
  • Zealand University Hospital

    collaborator OTHER
  • Sygehus Lillebaelt

    collaborator OTHER
  • Nykøbing Falster County Hospital

    collaborator OTHER
  • Regional Hospital West Jutland

    collaborator OTHER
  • Bornholm Hospital

    collaborator UNKNOWN
  • University of Southern Denmark

    lead OTHER

Principal Investigators

  • Bjarke Viberg, MD, PhD · Department of Orthopaedic Surgery and Traumatology, Lillebaelt Hospital

  • Ole Brink, MD, PhD · Department of Orthopaedic Surgery and Traumatology, Aarhus University Hospital

  • Søren Kold, Professor · Department of Orthopaedic Surgery and Traumatology, Aalborg University Hospital

  • Morten S Larsen, MD · Odense University Hospital

  • Kristoffer B Hare, MD, PhD · Department of Orthopaedic Surgery and Traumatology, Slagelse Hospital

  • Henrik Palm, MD, DmSc · Department of Orthopaedic Surgery and Traumatology, Bispebjerg Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-01
Primary Completion
2024-01-26
Completion
2025-01-26

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04075461 on ClinicalTrials.gov